$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Prevalence and Risk Factors of Irritable Bowel Syndrome in Asia 원문보기

Journal of neurogastroenterology and motility, v.16 no.1, 2010년, pp.5 - 7  

Lee, Oh Young (Department of Internal Medicine, Digestive Disease Center, Hanyang University College of Medicine, Seoul, Korea.)

초록이 없습니다.

참고문헌 (31)

  1. 1 Drossman DA Whitehead WE Camilleri M Irritable bowel syndrome: a technical review for practice guideline development Gastroenterology 1997 112 2120 2137 9178709 

  2. 2 Thompson WG Longstreth GF Drossman DA Heaton KW Irvine EJ Mueller-Lissner SA Drossman DA Talley NJ Thompson WG Whitehead WE Corazziari E C. Functional bowel disorders and D. Functional abdominal pain Rome II: functional gastrointestinal disorders: diagnosis, pathophysiology, and treatment 2000 2nd ed McLean Degnon Associates Inc. 351 432 

  3. 3 Talley NJ Zinsmeister AR Melton LJ 3rd Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization Am J Epidemiol 1995 142 76 83 7785677 

  4. 4 Jones R Lydeard S Irritable bowel syndrome in the general population BMJ 1992 304 87 90 1737146 

  5. 5 Kennedy TM Jones RH Epidemiology of cholecystectomy and irritable bowel syndrome in a UK Population Br J Surg 2000 87 1658 1663 11122180 

  6. 6 Masud MA Hasan M Kahn AK Irritable bowel syndrome in a rural community in Bangladesh: prevalence, symptoms pattern, and health care seeking behavior Am J Gastroenterol 2001 96 1547 1552 11374697 

  7. 7 Longstreth GF Wolde-Tsadik G Irritable bowel-type symptoms in HMO examinees Dig Dis Sci 1993 38 1581 1589 8359067 

  8. 8 Danivat D Tankeyoon M Sriratanaban A Prevalence of irritable bowel syndrome in a non-Western population BMJ 1988 296 1710 3135889 

  9. 9 Han SH Lee OY Bae SC Prevalence of irritable bowel syndrome in Korea: population-based survey using the Rome II criteria J Gastroenterol Hepatol 2006 21 1687 1692 16984590 

  10. 10 Kwan AC Hu WH Chan YK Yeung YW Lai TS Yuen H Prevalence of irritable bowel syndrome in Hong Kong J Gastroenterol Hepatol 2002 17 1180 1186 12453277 

  11. 11 Xiong LS Chen MH Chen HX Xu AG Wang WA Hu PJ A population-based epidemiologic study of irritable bowel syndrome in South China: stratified randomized study by cluster sampling Aliment Pharmacol Ther 2004 19 1217 1224 15153175 

  12. 12 Lee SY Lee KJ Kim SJ Cho SW Prevalence and risk factors for overlaps between gastroesophageal reflux disease, dyspepsia, and irritable bowel syndrome: a population-based study Digestion 2009 79 196 201 19342860 

  13. 13 Wang AJ Liao XH Hu PJ Liu SC Xiong LS Cheu MH A comparison between Rome III and Rome II criteria in diagnosing irritable bowel syndrome Zhonghua Nei Ke Za Zhi 2007 46 644 647 17967234 

  14. 14 Dorn SD Morris CB Hu Y Irritable bowel syndrome subtypes defined by Rome II and Rome III criteria are similar J Clin Gastroenterol 2009 43 214 220 19623100 

  15. 15 Sperber AD Shvartzman P Friger M Fich A A comparative reappraisal of the Rome II and Rome III diagnostic criteria: are we getting closer to the 'true' prevalence of irritable bowel syndrome? Eur J Gastroenterol Hepatol 2007 19 441 447 17489053 

  16. 16 Miwa H Prevalence of irritable bowel syndrome in Japan: internet survey using Rome III criteria Patient Prefer Adherence 2008 2 143 147 19920955 

  17. 17 Boyce PM Koloski NA Talley NJ Irritable bowel syndrome according to varying diagnostic criteria, are the new Rome II criteria unnecessarily restrictive for research and practice? Am J Gastroenterol 2000 95 3176 3183 11095338 

  18. 18 Mearin F Badia X Balboa A Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population Scand J Gastroenterol 2001 36 1155 1161 11686214 

  19. 19 Thompson WG Irvine EJ Pare P Ferrazzi S Rance L Functional disorders in Canada: First population-based survey using Rome II criteria with suggestions for improving the questionnaire Dig Dis Sci 2002 47 225 235 11837727 

  20. 20 Gwee KA Lu CL Ghoshal UC Epidemiology of irritable bowel syndrome in Asia: something old, something new, something borrowed J Gastroenterol Hepatol 2009 24 1601 1607 19788601 

  21. 21 Jeong JJ Choi MG Cho YS Chronic gastrointestinal symptoms and quality of life in the Korean population World J Gastroenterol 2008 14 6388 6394 19009657 

  22. 22 Shen L Kong H Hou X Prevalence of irritable bowel syndrome and its relationship with psychological stress status in Chinese university students J Gastroenterol Hepatol 2009 24 1885 1890 19780881 

  23. 23 Rey E Talley NJ Irritable bowel syndrome: novel views on the epidemiology and potential risk factors Dig Liver Dis 2009 41 772 780 19665952 

  24. 24 Andrews EB Eaton SC Hollis KA Prevalence and demographics of irritable bowel syndrome: results from a large web-based survey Aliment Pharmacol Ther 2005 22 935 942 16268967 

  25. 25 Gomez Alvarez DF Morales Vargas JG Rojas Medina LM Mújica Oviedo SC Camacho López PA Rueda Jaimes GE Prevalence of irritable bowel syndrome and associated factors according to the Rome III diagnostic criteria in a general population in Colombia Gastroenterol Hepatol 2009 32 395 400 19520461 

  26. 26 Locke GR 3rd Yawn BP Wollan PC Melton LJ 3rd Lydick E Talley NJ Incidence of a clinical diagnosis of the irritable bowel syndrome in a United States population Aliment Pharmacol Ther 2004 19 1025 1031 15113370 

  27. 27 Hazlett-Stevens H Craske MG Mayer EA Chang L Naliboff BD Prevalence of irritable bowel syndrome among university students: the roles of worry, neuroticism, anxiety sensitivity and visceral anxiety J Psychosom Res 2003 55 501 505 14642979 

  28. 28 Nicholl BI Halder SL Mcfarlane GJ Psychosocial risk markers for new onset irritable bowel syndrome-results of a large prospective population-based study Pain 2008 137 147 155 17928145 

  29. 29 Gaman A Kuo B Neuromodulatory processes of the brain-gut axis Neuromodulation 2008 11 249 259 19844605 

  30. 30 Locke GR 3rd Zinsmeister AR Talley NJ Fett SL Melton LJ Risk factors for irritable bowel syndrome: role of analgesics and food sensitivities Am J Gastroenterol 2000 95 157 165 10638576 

  31. 31 Masand PS Sousou AJ Gupta S Kaplan PS Irritable bowel syndrome (IBS) and alcohol abuse or dependence Am J Drug Alcohol Abuse 1998 24 513 521 9741950 

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

이 논문과 함께 이용한 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로